Today: 14 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Coca‑Cola (KO) Stock on December 2, 2025: Price, Dividend Yield, Analyst Forecasts and 2025–2030 Outlook

Coca‑Cola (KO) Stock on December 2, 2025: Price, Dividend Yield, Analyst Forecasts and 2025–2030 Outlook

Coca‑Cola shares traded at $70.56 intraday on December 2, 2025, down 1.9% from the previous close, with a market cap near $309.5 billion. The stock sits near the top of its 52-week range and has returned about 16.6% over the past year. A new DCF analysis values KO at $89.90 per share, about 20% above current levels. Recent research highlights the company’s push into healthier beverages and ongoing dividend focus.
2 December 2025
·
Merck (MRK) Stock on December 2, 2025: Dividend Hike, FDA Wins and Fresh Wall Street Targets

Merck (MRK) Stock on December 2, 2025: Dividend Hike, FDA Wins and Fresh Wall Street Targets

Merck shares traded near $101 on December 2, 2025, down about 1%, with a market cap above $250 billion after a 22% rally in November. The company raised its quarterly dividend to $0.85 per share, effective January 2026. Merck’s stock remains below its 52-week high of $105.84 and trades at a forward P/E of 11–11.5x, below sector averages.
2 December 2025
···
Vertiv Stock (VRT) in December 2025: AI Data Center Deals, Q3 Beat and Fresh Wall Street Targets

Vertiv Stock (VRT) in December 2025: AI Data Center Deals, Q3 Beat and Fresh Wall Street Targets

Vertiv shares traded near $183 late on December 2, 2025, valuing the company at about $68.5 billion after soaring nearly 60% this year. The stock hit a 52-week high of $202.45 amid surging demand for data center power and cooling tied to AI workloads. Vertiv reported $8 billion in 2024 revenue and recently announced a strategic energy partnership with Caterpillar.
2 December 2025
··
Air Premia’s 15‑Hour Seoul–Washington 787 Flight and Etihad’s A380 to Tokyo Narita: How 2026 Is Reshaping Long‑Haul Travel

Air Premia’s 15‑Hour Seoul–Washington 787 Flight and Etihad’s A380 to Tokyo Narita: How 2026 Is Reshaping Long‑Haul Travel

South Korea’s Air Premia will launch nonstop Boeing 787-9 flights from Seoul Incheon to Washington Dulles on April 24, 2026, breaking Korean Air’s monopoly on the route. The service will run four times weekly, with flight times up to 15 hours due to Russian airspace restrictions. Air India’s exit from the Delhi–Dulles route has opened long-haul capacity at the airport.
2 December 2025
··
Adobe Stock (ADBE) Near 52‑Week Lows as AI Bets Grow: Latest News, Forecasts & Analysis for December 2, 2025

Adobe Stock (ADBE) Near 52‑Week Lows as AI Bets Grow: Latest News, Forecasts & Analysis for December 2, 2025

Adobe shares traded around $325 intraday on December 2, near the bottom of their 52-week range, despite Q3 earnings and guidance beating expectations. The stock is down 27% year-to-date and 38% over 12 months. Q3 revenue rose 10–11% to $5.99 billion, and AI-influenced annual recurring revenue surpassed $5 billion. Market reaction has remained muted as investors question future AI-driven growth.
2 December 2025
···
Coherent Corp (COHR) Stock Soars 62% YTD: Latest News, Analyst Forecasts and AI-Fueled Outlook as of December 2, 2025

Coherent Corp (COHR) Stock Soars 62% YTD: Latest News, Analyst Forecasts and AI-Fueled Outlook as of December 2, 2025

Coherent Corp (NYSE: COHR) traded near $165 per share late December 2, up less than 1% on the day and about 62% year-to-date. Market capitalization stands around $25–26 billion. Recent coverage highlights strong gains driven by expansion in photonics and silicon carbide for EVs, with debate over whether fundamentals justify the rally. Coherent’s Networking segment remains its main revenue driver.
2 December 2025
·
Dell Technologies Stock Jumps on $6.25 Billion Dell Family Gift and AI Server Boom – Latest News, Forecasts and Analysis (December 2, 2025)

Dell Technologies Stock Jumps on $6.25 Billion Dell Family Gift and AI Server Boom – Latest News, Forecasts and Analysis (December 2, 2025)

Dell Technologies shares rose about 2.6% to $135.55 Tuesday after founder Michael Dell and his wife pledged $6.25 billion to fund “Trump Accounts” for U.S. children. Trading volume neared 4 million shares, with options activity heavily favoring calls. President Trump publicly praised the donation. The stock earlier touched $138 as the news spread.
2 December 2025
·
Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts

Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts

Thermo Fisher Scientific shares traded near $580 midday Tuesday, down less than 1% but close to their 52-week high of $611. HSBC raised its price target on the stock to $670. The company recently announced a €2.1 billion bond sale and a $5 billion share repurchase plan. An insider filed to sell 6,912 shares valued at about $4 million.
2 December 2025
··
Uber Stock (NYSE: UBER) on December 2, 2025: Earnings Power, Institutional Buying and Robotaxis Drive the 2026 Outlook

Uber Stock (NYSE: UBER) on December 2, 2025: Earnings Power, Institutional Buying and Robotaxis Drive the 2026 Outlook

Uber shares traded around $87–88 midday December 2, 2025, valuing the company near $180 billion. The stock remains below its 52-week high of $102 but is up 21% over the past year. Institutional investors increased stakes while insiders, including CEO Dara Khosrowshahi, sold shares worth over $55 million in the past 90 days. Uber reported strong Q3 results and raised Q4 guidance.
2 December 2025
···
Exxon Mobil (XOM) Stock on December 2, 2025: West Qurna Deal Talks, Hydrogen Pivot and 2026 Price Targets

Exxon Mobil (XOM) Stock on December 2, 2025: West Qurna Deal Talks, Hydrogen Pivot and 2026 Price Targets

Exxon Mobil shares traded near $115 midday December 2, down about 1% and several percent below the 52-week high of $120.81. Reuters reported Exxon has approached Iraq about acquiring Lukoil’s majority stake in the West Qurna 2 oilfield. The company has paused a major Texas hydrogen project and continues to rely on production from Guyana and the Permian Basin.
2 December 2025
·
Oklo Stock (OKLO) on December 2, 2025: Bubble, Breakthrough – or Both? Latest News, Forecasts & Analysis

Oklo Stock (OKLO) on December 2, 2025: Bubble, Breakthrough – or Both? Latest News, Forecasts & Analysis

Oklo Inc. shares traded near $92–$93 late morning on December 2, up 5–6% from Monday, after a year marked by a 340% rise and a sharp drop from a $193 peak. The company, valued at about $14.4 billion, remains pre-revenue with a net loss of $76.6 million over the past year. Short interest is around 15% of free float. Oklo develops small advanced nuclear reactors aimed at data centers and industrial power.
2 December 2025
·
Western Digital (WDC) Stock: Citi Lifts Target to $200 as AI Storage Boom Collides With Rich Valuation – December 2, 2025 Update

Western Digital (WDC) Stock: Citi Lifts Target to $200 as AI Storage Boom Collides With Rich Valuation – December 2, 2025 Update

Western Digital shares traded near $160 on December 2, 2025, after a year-to-date rally of about 260%, leading the S&P 500. Citigroup raised its price target to $200, while some models flagged the stock as potentially overvalued. The company spun off SanDisk in February and now focuses on hard-disk drives for AI and cloud storage. Western Digital reported Q4 revenue of $2.61 billion and reinstated its quarterly dividend.
2 December 2025
··
Bank of America Stock (BAC) Today: Buffett Trims Stake as Crypto Pivot and 2026 Outlook Shape the Bull Case – December 2, 2025

Bank of America Stock (BAC) Today: Buffett Trims Stake as Crypto Pivot and 2026 Outlook Shape the Bull Case – December 2, 2025

Bank of America traded near $53.30 on December 2, just below its all-time high, with a market cap around $390 billion and a year-to-date return of about 24%. Warren Buffett has continued reducing his stake. BofA Global Research issued a bullish 2026 macro outlook, projecting 2.4% U.S. GDP growth and modest equity gains. Analysts have upgraded the stock, citing technical signals that could precede a breakout.
2 December 2025
·
Applied Digital (APLD) Stock Jumps on Corintis Deal: Fresh AI Data‑Center Milestones and 2026–2030 Forecasts Explained

Applied Digital (APLD) Stock Jumps on Corintis Deal: Fresh AI Data‑Center Milestones and 2026–2030 Forecasts Explained

Applied Digital announced a $25 million investment in Swiss chip-cooling firm Corintis on December 2, sending its shares up 5–6% intraday. The stock traded near $29.80, valuing the company at $8–8.5 billion, up nearly 200–270% over the past year. Corintis develops liquid-cooling technology for AI data centers, with Microsoft among early testers.
2 December 2025
···
MongoDB (MDB) Stock Soars Over 20% After Blowout Q3 Earnings and AI Momentum – Latest News, Analyst Upgrades & 2026–2027 Outlook

MongoDB (MDB) Stock Soars Over 20% After Blowout Q3 Earnings and AI Momentum – Latest News, Analyst Upgrades & 2026–2027 Outlook

MongoDB shares surged 24% to around $408 Tuesday after Q3 revenue beat estimates at $628.3 million, up 19% year-over-year, and adjusted EPS reached $1.32 versus $0.79 expected. The company raised full-year revenue guidance to as high as $2.439 billion. Atlas cloud revenue grew 30% and now accounts for about 75% of total sales. Wall Street analysts responded with multiple price target hikes.
2 December 2025
···
Marvell Technology (MRVL) Stock: Celestial AI Deal Rumors, Q3 Earnings Preview and Analyst Targets as of December 2, 2025

Marvell Technology (MRVL) Stock: Celestial AI Deal Rumors, Q3 Earnings Preview and Analyst Targets as of December 2, 2025

Marvell Technology shares traded near $93 midday December 2, up over 2%, as Reuters reported the company is in advanced talks to acquire photonics startup Celestial AI for over $5 billion. Investors also awaited Marvell’s Q3 results due after the close. The stock’s market cap stands in the high-$70 billion range, with a forward P/E in the high-20s to low-30s and a price-to-sales ratio around 11.
2 December 2025
·
Johnson & Johnson (JNJ) Stock Near Record Highs: New EU Drug Approval, Oncology Deal and 2026 Outlook

Johnson & Johnson (JNJ) Stock Near Record Highs: New EU Drug Approval, Oncology Deal and 2026 Outlook

Johnson & Johnson closed at $206.92 on December 2, just below its record high of $207.56 from November 26. The company’s market cap stands near $500 billion after a 30% year-to-date stock surge, outpacing the S&P 500. Recent gains follow strong earnings, higher 2025 guidance, a new EU drug approval, and a $3.05 billion oncology acquisition.
2 December 2025
··
Applied Materials (AMAT) Stock Hits New Highs as Wall Street Lifts Targets on AI Boom – December 2, 2025 Outlook

Applied Materials (AMAT) Stock Hits New Highs as Wall Street Lifts Targets on AI Boom – December 2, 2025 Outlook

Applied Materials shares hit a record high near $261.71 on December 2, up about 41% over the past year. The company reported record fiscal 2025 revenue of $28.37 billion and non-GAAP EPS of $9.42. Analysts raised price targets, but AMAT faces a $600 million revenue hit in 2026 from U.S. export controls and is cutting 1,400 jobs.
2 December 2025
··
1 … 772 773 774 775 776 … 811

Stock Market Today

  • Siren Exits Ascendis Pharma with $50 Million Sale Amid Strong Quarterly Performance
    May 14, 2026, 3:43 PM EDT. On May 14, 2026, investment fund Siren sold its entire stake in Ascendis Pharma A/S, offloading 235,862 shares in a $52.87 million transaction based on first-quarter average prices. The divestment reduced Siren's position by approximately $50.3 million, including sales and market price effects. Despite this exit, Ascendis shares have risen 50% over the past year, outperforming the S&P 500 by 24 percentage points. The Danish biopharma company recently reported robust Q1 results, with revenue doubling to 247 million euros driven by sales of YORVIPATH and SKYTROFA, and recorded a net profit boosted by a deferred tax asset. Ascendis focuses on rare endocrine and pediatric diseases using its TransCon technology. Siren's sale does not signal a negative outlook amid Ascendis' strong momentum and expanding rare disease patient base.

Latest articles

REGENXBIO Stock Plunges as Duchenne Gene Therapy Win Runs Into Safety Questions

REGENXBIO Stock Plunges as Duchenne Gene Therapy Win Runs Into Safety Questions

14 May 2026
REGENXBIO shares fell 37% to $6.31 after its Duchenne muscular dystrophy gene therapy, RGX-202, met the main goal in a late-stage trial. Investors reacted to two serious adverse events and uncertainty over FDA approval. The company reported 93% of patients showed microdystrophin expression at 12 weeks. REGENXBIO said it will seek accelerated approval and targets a 2027 launch.
Digi Power X Stock Slides Before Earnings as $1.1 Billion AI Deal Faces First Test

Digi Power X Stock Slides Before Earnings as $1.1 Billion AI Deal Faces First Test

14 May 2026
Digi Power X shares fell 14% to $7.28 in heavy trading Thursday ahead of its first-quarter results and operations update due May 15. Investors are focused on its $1.1 billion, 10-year AI data-center deal with Cerebras and a $19.6 million SubQ AI GPU rental contract launching Friday. The company also expanded its at-the-market share-sale program to $175 million.
Smart Powerr Stock Nearly Quadruples as Nasdaq Delisting Threat Shadows CREG

Smart Powerr Stock Nearly Quadruples as Nasdaq Delisting Threat Shadows CREG

14 May 2026
Smart Powerr shares jumped to 78.83 cents, up nearly 59 cents from the previous close, after hitting 90.37 cents intraday. The surge followed news that Nasdaq warned the company over its sub-$1 share price and possible suspension. Trading volume reached about 395 million shares. The company said a hearing request would delay any suspension but gave no assurance of keeping its Nasdaq listing.
Go toTop